Feb 27, 2019
This week's View focuses on heart disease in women, addressing the long-term risk of developing heart failure (HF) after trastuzumab therapy, how sex differences contribute to exercise intolerance in patients with HF with preserved ejection fraction, and gender differences in adverse drug reactions to HF medication.